A0A7P0T8D1 (A0A7P0T8D1_HUMAN) Homo sapiens (Human)
Angiotensinogen UniProtKBInterProInteractive Modelling
476 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P01019
Available Structures
22 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom |
Heteromer P00797; P01019; | 99.03 | 1×NAG; 1×NAG; 10×SO4; 1×GOL; | |||
| Crystal structure of human angiotensinogen complexed with renin |
Heteromer P00797; P01019; | 99.76 | ||||
| Human angiotensin-converting enzyme in complex with angiotensin-II |
Heteromer P01019; P12821; | 100 | 1×NAG; 2×CL; 1×ZN; 1×PE4; 1×NAG; 5×ACT; | |||
| Structure of human DPP3 in complex with angiotensin-II |
Heteromer P01019; Q9NY33; | 100 | 1×MG; 1×K; | |||
| Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II |
Heteromer P01019; P0ABE7; P30556; | 100 | 1×NAG; 2×CL; | |||
| ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II |
Heteromer P01019; P01837; | 100 | ||||
| Angiotensin II type 2 receptor with ligand |
Heteromer P01019; P0ABE7; P50052; | 100 | ||||
| Human aminopeptidase N (CD13) in complex with angiotensin IV |
Heteromer P01019; P15144; | 100 | 1×NAG; 1×NAG; 5×NAG; 11×SO4; | |||
| Crystal structure of the DAP BII octapeptide complex |
Heteromer P01019; V5YM14; | 100 | 9×GOL; 4×ZN; | |||
| Complex structure of angiotensin II type 2 receptor with Fab |
Heteromer P01019; P0ABE7; P50052; | 100 | ||||
| Crystal structure of AT2R-BRIL and SRP2070_Fab complex |
Heteromer P01019; P0ABE7; P50052; | 100 | ||||
| Crystal structure of the DAP BII hexapeptide complex I |
Heteromer P01019; V5YM14; | 100 | 12×GOL; 4×ZN; | |||
| Crystal structure of ANCE in complex with Angiotensin-II |
Heteromer P01019; Q10714; | 100 | 1×NAG; 1×ZN; 2×NAG; | |||
| E. coli Microcin-processing metalloprotease TldD/E with DRVY angiotensin fragment bound |
Heteromer P01019; P0AFK0; P0AGG8; | 100 | 1×ZN; 2×MES; 5×EDO; 2×NA; | |||
| E. coli Microcin-processing metalloprotease TldD/E with angiotensin analogue bound |
Heteromer P01019; P0AFK0; P0AGG8; | 100 | 1×ZN; 2×MES; 5×EDO; 2×NA; | |||
| Crystal structure of human glycosylated angiotensinogen | monomer | 98.8 | 1×NAG; | |||
| Crystal structure of reactive center loop (RCL) cleaved angiotensinogen | monomer | 98.83 | 1×NAG; | |||
| Crystal structure of human angiotensinogen | monomer | 100.0 | ||||
| Crystal structure of human angiotensin I-deleted angiotensinogen | monomer | 98.96 | ||||
| Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structur… | monomer | 100 | ||||
| Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structur… | monomer | 100 | ||||
| Angiotensin 1-7 | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2wxw.1.A | monomer | 0.80 | 100.00 | |||